AVRAnteris Technologies Global Corp.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Revenue
- $2M
- 29% YoY
- Operating margin
- -4908.2%
- 69% YoY
- EBITDA
- −$92M
- 20% YoY
- Market cap
- $615M
- Employees
- 174
- $11K revenue each
- Net debt / EBITDA
- —
- −$250M net debt
- AI in 10-K
- 1.9
- mentions per 10K words
Takeover score 3 of 13
Fixable underperformance 1 of 7
- TSR below peersNo—3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCYes407% of revenueOver 10% of revenue
- Payouts exceed cash flowNo0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo—Over 40% of assets
- Shareholder dissentNo86% lowest supportAny vote under 80% support
Buyer economics 2 of 4
- Low revenue per employeeYes$11K · 3rd pctBottom quartile of its SIC industry
- Quiet on AINo1.9 per 10K words · 53rd pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$615M market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo$15M netNet sales over $10M in 12 months
Financials
| Metric | FY2024 | FY2025 | YoY |
|---|---|---|---|
| Revenue | $3M | $2M | 29% |
| Operating income | −$78M | −$94M | 20% |
| Net income | −$76M | −$94M | 23% |
| Operating cash flow | −$61M | −$78M | 27% |
| Capex | $2M | $2M | 14% |
| Stock-based comp | $7M | $8M | 19% |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| Jan 29, 2026 | Medtronic plc | SCHEDULE 13D | 16.2% | Passive |
Insider trading
- Open-market buys, 12 mo
- $41M · 7
- Open-market sells, 12 mo
- $25M · 13
- Net
- $15M
Pay vs performance
No pay-versus-performance disclosure yet.